These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37199610)

  • 21. Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages.
    Nzula S; Vandamme P; Govan JR
    FEMS Immunol Med Microbiol; 2000 Aug; 28(4):307-12. PubMed ID: 10891654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children.
    Power RF; Linnane B; Martin R; Power N; Harnett P; Casserly B; O'Connell NH; Dunne CP
    BMC Pulm Med; 2016 Apr; 16(1):57. PubMed ID: 27103163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SNaPBceBcon: a Practical Tool for Identification and Genotyping of Burkholderia cepacia and Burkholderia contaminans.
    Araujo R; Caramalho R; Coutinho C; Sá-Correia I
    J Clin Microbiol; 2016 Feb; 54(2):483-8. PubMed ID: 26659211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex.
    Seed KD; Dennis JJ
    Antimicrob Agents Chemother; 2009 May; 53(5):2205-8. PubMed ID: 19223640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex.
    Lynch KH; Stothard P; Dennis JJ
    BMC Genomics; 2010 Oct; 11():599. PubMed ID: 20973964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages.
    Lynch KH; Stothard P; Dennis JJ
    BMC Genomics; 2012 Jun; 13():223. PubMed ID: 22676492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of Burkholderia cepacia Complex Methylomes via Single-Molecule, Real-Time Sequencing and Mutant Analysis.
    Mannweiler O; Pinto-Carbó M; Lardi M; Agnoli K; Eberl L
    J Bacteriol; 2021 May; 203(12):e0068320. PubMed ID: 33753468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Genetic relatedness of Burkholderia contaminans clinical isolates from cystic fibrosis and non-cystic fibrosis patients in Argentina.
    Cipolla L; Prieto M; Faccone D
    J Infect Dev Ctries; 2022 May; 16(5):835-842. PubMed ID: 35656955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions.
    Lynch KH; Seed KD; Stothard P; Dennis JJ
    J Virol; 2010 Feb; 84(3):1276-88. PubMed ID: 19939932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basic Guidelines for Bacteriophage Isolation and Characterization.
    Samir S
    Recent Pat Biotechnol; 2023; 17(4):312-331. PubMed ID: 36263478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases.
    Degrossi JJ; Merino C; Isasmendi AM; Ibarra LM; Collins C; Bo NE; Papalia M; Fernandez JS; Hernandez CM; Papp-Wallace KM; Bonomo RA; Vazquez MS; Power P; Ramirez MS
    Curr Microbiol; 2019 Apr; 76(4):485-494. PubMed ID: 30783798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of clonally-related Burkholderia contaminans strains in two patients attending an Italian cystic fibrosis centre: a case report.
    Savi D; Quattrucci S; Trancassini M; Dalmastri C; De Biase RV; Maggisano M; Palange P; Bevivino A
    BMC Pulm Med; 2019 Aug; 19(1):164. PubMed ID: 31464603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug-resistant Burkholderia multivorans.
    Haidar G; Chan BK; Cho ST; Hughes Kramer K; Nordstrom HR; Wallace NR; Stellfox ME; Holland M; Kline EG; Kozar JM; Kilaru SD; Pilewski JM; LiPuma JJ; Cooper VS; Shields RK; Van Tyne D
    Transpl Infect Dis; 2023 Apr; 25(2):e14041. PubMed ID: 36864824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recipient Cell Factors Influence Interbacterial Competition Mediated by Two Distinct Burkholderia dolosa Contact-Dependent Growth Inhibition Systems.
    Elery ZK; Oates AE; Myers-Morales T; Garcia EC
    J Bacteriol; 2022 Sep; 204(9):e0054121. PubMed ID: 36000834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis.
    Nunvar J; Kalferstova L; Bloodworth RA; Kolar M; Degrossi J; Lubovich S; Cardona ST; Drevinek P
    PLoS One; 2016; 11(8):e0160975. PubMed ID: 27512997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.
    Bernier SP; Son S; Surette MG
    J Bacteriol; 2018 Sep; 200(18):. PubMed ID: 29986943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriophage Isolation, Purification, and Characterization Techniques Against Ubiquitous Opportunistic Pathogens.
    Peters DL; Harris G; Davis CM; Dennis JJ; Chen W
    Curr Protoc; 2022 Nov; 2(11):e594. PubMed ID: 36383057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.